Article
Overview of the pharmacogenetics of asthma treatment.
The pharmacogenomics journal - 1 Jan 2000
Weiss S T, Litonjua A A, Lange C, Lazarus R, Liggett S B, Bleecker E R, Tantisira K G
Abstract excerpt
Asthma affects approximately 300 million individuals worldwide. Medications comprise a substantial portion of asthma expenditures. Despite the availability of three primary therapeutic classes of medications, there are a significant number of nonresponders to therapy. Available data, as well as previous pharmacogenetic studies, suggest that genetics may contribute as much as 60-80% to the interindividual...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.